Clinical Trial Update: Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the safety and efficacy of a sublingual six-grass pollen extract for grass pollen allergy; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Grass Pollen Allergy

Drugs mentioned

• Sublingual immunotherapy extract (six grass pollen mix) (grass pollen extract (six grass pollen mix))

Snippet

Sponsor: Allergopharma GmbH & Co. KG | Conditions: Grass Pollen Allergy | Phase 3 | Status: COMPLETED